Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Net Income Attributable to Noncontrolling Interests (2023 - 2025)

Updated

Abeona Therapeutics (ABEO) posted Net Income Attributable to Noncontrolling Interests of $71.31 million for FY2025, compared with -$63.66 million in FY2024.

Analysis

Abeona Therapeutics (ABEO) Net Income Attributable to Noncontrolling Interests (2023 - 2025) Analysis & Trends

  • Business Quant data shows ABEO's Net Income Attributable to Noncontrolling Interests at -$63.66 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCI Net Income (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 2.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 2.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -1.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 10.00 Mn
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 108.86 Mn
Jun 30, 2024 7.46 Mn
Jun 30, 2023 -16.68 Mn
API Access

Abeona Therapeutics Net Income Attributable to Noncontrolling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ABEO&period=max&api_key=YOUR_API_KEY